EUS-guided hepaticogastrostomy versus EUS-guided hepaticogastrostomy with antegrade stent placement in patients with unresectable malignant distal biliary obstruction: a meta-analysis of individual patient data - Top-Institutions - MDSpire

EUS-guided hepaticogastrostomy versus EUS-guided hepaticogastrostomy with antegrade stent placement in patients with unresectable malignant distal biliary obstruction: a meta-analysis of individual patient data

  • By

  • Mahmoud Shaaban Abdelgalil

  • Ahmad Abdelrazek

  • Mahmoud Samir Mohamed

  • Amro Hassan

  • Manar Alaa Mabrouk

  • Mohamed Nasser

  • Eyad Khalil Alhmeid

  • Abdullah Nizar

  • Abid Wazir

  • Noha Ali

  • Adam Hraybi

  • Ryad iqbal

  • Sadia Paracha

  • Shray Amin

  • July 11, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Gastroenterology
    • GI Surgery

  • #2

    The Johns Hopkins Hospital
    The Johns Hopkins Hospital

    Baltimore, Maryland

    Key Differentiators

    • Gastroenterology
    • GI Surgery

  • #3

    Zagazig University Hospitals
    Zagazig University Hospitals

    Zagazig, Egypt

    Key Differentiators

    • Gastroenterology

  • #4

    Tampere University Hospital
    Tampere University Hospital

    Tampere, Finland

    Key Differentiators

    • Gastroenterology

  • #5

    University Hospital Southampton NHS Foundation Trust
    University Hospital Southampton NHS Foundation Trust

    Southampton, United Kingdom

    Key Differentiators

    • Gastroenterology

Original Source(s)

EUS-guided hepaticogastrostomy versus EUS-guided hepaticogastrostomy with antegrade stent placement in patients with unresectable malignant distal biliary obstruction: a meta-analysis of individual patient data

  • by Mahmoud Shaaban Abdelgalil, Ahmad Abdelrazek, Mahmoud Samir Mohamed, Amro Hassan, Manar Alaa Mabrouk, Mohamed Nasser, Eyad Khalil Alhmeid, Abdullah Nizar, Abid Wazir, Noha Ali, Adam Hraybi, Ryad iqbal, Sadia Paracha, Shray Amin

  • July 11, 2026

Related Content

Risk of Infections With Infliximab vs Adalimumab Among Children With Inflammatory Bowel Disease

Long-term outcomes of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer: a prospective phase II study

Engineering allogeneic type 1 regulatory T cells: a scalable, off-the-shelf platform for restoring immune tolerance